ARCH Venture Fund VIII L.P. 13D and 13G filings for Denali Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-08 3:04 pm Sale | 2021-12-31 | 13G | Denali Therapeutics Inc. DNLI | ARCH Venture Fund VIII L.P. | 0 0.000% | -10,735,948 (Position Closed) | Filing |
| 2021-02-02 5:04 pm Purchase | 2020-12-31 | 13G | Denali Therapeutics Inc. DNLI | ARCH Venture Fund VIII L.P. | 10,735,948 9.000% | 37,339 (+0.35%) | Filing |
| 2020-02-13 4:52 pm Sale | 2019-12-31 | 13G | Denali Therapeutics Inc. DNLI | ARCH Venture Fund VIII L.P. | 10,698,609 11.100% | -370,140 (-3.34%) | Filing |